fda drug shortage semaglutide Ozempic and Wegovy are no longer in shortage, says π¨ FDA Moves to Permanently
Description
Tirzepatide 5mg helps treat appetite imbalance and support healthy weight management Dual GIP/GLP-1 receptor agonist for blood sugar control and significant weight reduction
[DOI] [PMC free article] [PubMed] [Google Scholar] 4.Mulhall JP, Trost LW, Brannigan RE, et al
Its only available in its branded form, and a generic alternative likely wont be available until the early 2030s
The lawsuit claims the manufacturer failed to adequately warn about the risk of serious gastrointestinal side effects
August 1, 2025: New Litigation May Form for Zepbound Injuries An increasing number of studies support that GLP-1 drugs like Zepbound increase the risk of an eye disease called NAION (nonarteritic anterior ischemic optic neuropathy)
By improving insulin secretion, reducing glucagon levels, and slowing gastric emptying, semaglutide can significantly improve blood sugar control
